Opportunity Information: Apply for CDC RFA GH21 2104
This CDC cooperative agreement (RFA number CDC RFA GH21-2104; CFDA 93.084) focuses on helping countries and partners strengthen real-world, on-the-ground programs to eliminate lymphatic filariasis (LF) and to eliminate, eradicate, or control several other neglected tropical diseases (NTDs). The opportunity is rooted in the fact that NTDs affect more than one billion people worldwide, largely in the poorest settings, and that many of these diseases can be reduced dramatically with practical, tool-ready public health approaches rather than new scientific discovery. The grant is explicitly for non-research work; applications proposing research activities are not eligible for review under this announcement.
The diseases emphasized are six NTDs that CDC and global partners prioritize for large-scale public health action: lymphatic filariasis, onchocerciasis, trachoma, soil-transmitted helminths, schistosomiasis, and Guinea worm. The core program methods include community-based mass drug administration (MDA) campaigns, plus other proven interventions such as water filters (especially relevant to Guinea worm), vector control, and improvements in water, sanitation, and hygiene (WASH). The overall intent is to improve the quality, reach, and performance of local and national programs so they can hit coverage targets, maintain gains, and prevent diseases from resurging after progress is made.
A major emphasis is lymphatic filariasis, a mosquito-borne parasitic disease that can cause lifelong disability, including elephantiasis and hydrocele. LF had a global elimination target of 2020; while that deadline was not fully achieved, notable progress has been made, including 16 countries that have eliminated LF as a public health problem, and many others that are close. The announcement highlights why finishing the job can be difficult, especially in challenging environments like densely populated urban areas, where achieving consistently high participation can be harder. Standard LF elimination strategy depends on delivering antiparasitic medicines through MDA with high community coverage (generally greater than 65 percent) for at least five years to interrupt transmission. Because coverage and adherence drive success, the funding prioritizes locally tailored strategies that raise participation, reduce systematic non-compliance (people repeatedly missing or refusing treatment), and improve campaign quality.
The opportunity also reflects newer operational guidance: in some settings, adding ivermectin to the traditional two-drug regimen of diethylcarbamazine (DEC) plus albendazole (often referred to as triple-drug therapy) can reduce the number of annual MDA rounds needed, but only if high community coverage is achieved. Beyond the MDA phase, the announcement stresses that programs must be able to decide when it is appropriate to stop MDA and must be ready to detect and respond if infection returns. That means building feasible, sustainable surveillance systems that can identify recrudescence (a rebound in transmission) and establishing clear procedures to manage hotspots or persistent transmission areas so spread is contained quickly.
For the other NTDs, the grant frames the end goals in a disease-specific way: Guinea worm has eradication potential, onchocerciasis and trachoma can be eliminated as public health problems in many settings, and schistosomiasis and soil-transmitted helminths are typically targeted for control through repeated, high-quality campaigns. Across these diseases, the announcement underscores the same basic requirement: sustained, well-run community campaigns paired with strong monitoring, evaluation, and surveillance over time, including post-elimination surveillance where relevant. Integration is another theme, meaning NTD services and surveillance should be increasingly built into existing national health systems rather than operating as isolated vertical programs, which supports long-term sustainability.
The expected measurable outcomes are operational and performance-based. For LF, the outcomes include improved quality and access to MDA campaigns, higher community participation, and clearer insight into why people do or do not take treatment so programs can address barriers directly. The grant also aims to strengthen care and management for chronic LF-related disease in affected communities, improve decision-making around MDA stopping points, and build strong systems for monitoring, evaluation, and surveillance before, during, and after MDA, including targeted management of hotspots. For other NTDs, outcomes similarly focus on better MDA quality, better determination of when to start and stop campaigns (with onchocerciasis given as an example), higher-quality monitoring and surveillance including after elimination, and deeper integration of NTD activities into routine health services.
Administratively, this is a discretionary funding opportunity offered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), through CDCs Center for Global Health (CGH) and supported technically by the Division of Parasitic Diseases and Malaria (DPDM), which has long experience providing technical assistance alongside WHO and national ministries of health. The funding instrument is a cooperative agreement, which typically signals substantial involvement and collaboration with CDC during implementation. Eligibility is broad and includes many types of U.S.-based and other entities listed in the notice (governments, universities, nonprofits, for-profits, small businesses, tribal entities, and others as specified). The original posting dates indicate it was created December 18, 2020, with an original closing date of February 19, 2021, and an expectation of four awards; the award ceiling is listed as 0 in the source data, which generally means the ceiling was not specified in that field rather than implying no funding.Apply for CDC RFA GH21 2104
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Elimination of lymphatic filariasis and elimination and control of other neglected tropical diseases (NTDs) in an effort to improve the quality and coverage of local programs." and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.084.
- This funding opportunity was created on Dec 18, 2020.
- Applicants must submit their applications by Feb 19, 2021 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification), Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: European Regional Hackathon to Promote U.S.-Europe Cooperation in Space
Previous opportunity: 2021 National Geological & Geophysical Data Preservation Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH21 2104
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH21 2104) also looked into and applied for these:
| Funding Opportunity |
|---|
| State Pilot Grant Program for Treatment for Pregnant and Postpartum Women Apply for TI 21 002 Funding Number: TI 21 002 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $3,000,000 |
| Tribal Opioid Response Grants Apply for TI 21 007 Funding Number: TI 21 007 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $37,647,916 |
| Partnering and Communicating Together Apply for CDC RFA PS21 2104 Funding Number: CDC RFA PS21 2104 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Program Part F Dental Reimbursement Program Apply for HRSA 21 056 Funding Number: HRSA 21 056 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Using Innovative Intervention Strategies to Improve Health Outcomes among People with HIV - Evaluation Center Apply for HRSA 21 068 Funding Number: HRSA 21 068 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Using Innovative Intervention Strategies to Improve Health Outcomes among People with HIV - Coordinating Center Apply for HRSA 21 076 Funding Number: HRSA 21 076 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Supporting and Improving the Chronic Kidney Disease Surveillance System in the United States Apply for CDC RFA DP21 2107 Funding Number: CDC RFA DP21 2107 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $1,200,000 |
| Rural Communities Opioid Response Program - Implementation Apply for HRSA 21 088 Funding Number: HRSA 21 088 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $1,000,000 |
| Health Promotion and Disease Prevention Research Centers: 2021 Special Interest Project Competitive Supplements (SIPS) Apply for RFA DP 21 004 Funding Number: RFA DP 21 004 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $3,785,000 |
| THRIVE Water Sanitation and Hygiene Activity Apply for 72069621RFA00001 Funding Number: 72069621RFA00001 Agency: Agency for International Development, Rwanda USAID-Kigali Category: Health Funding Amount: $21,000,000 |
| Certified Community Behavioral Health Clinic Expansion Grants Apply for SM 21 013 Funding Number: SM 21 013 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $2,000,000 |
| Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory Pathogens in South Africa Apply for RFA IP 21 003 Funding Number: RFA IP 21 003 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $1,250,000 |
| Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth Apply for RFA CE 21 003 Funding Number: RFA CE 21 003 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $125,000 |
| Research Grants for Preventing Violence and Violence Related Injury (R01) Apply for RFA CE 21 004 Funding Number: RFA CE 21 004 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $350,000 |
| Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths Apply for SP 21 002 Funding Number: SP 21 002 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $850,000 |
| Developing and Disseminating Targeted Immunization Materials Apply for CDC RFA IP21 2104 Funding Number: CDC RFA IP21 2104 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
| Maternal and Child Health Workforce Development Center Program Apply for HRSA 21 043 Funding Number: HRSA 21 043 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $1,970,000 |
| STOP DJEKOIDJO Apply for 72062421RFA00002 Funding Number: 72062421RFA00002 Agency: Agency for International Development, Cote d Ivoire USAID - Abidjan Category: Health Funding Amount: $19,500,000 |
| Paul Coverdell National Acute Stroke Program Apply for CDC RFA DP21 2102 Funding Number: CDC RFA DP21 2102 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $650,000 |
| Next Generation Sequencing in Post Mortem Tissue from Patients with Parkinsons Disease (U01 Clinical Trial Not Allowed) Apply for RFA NS 21 017 Funding Number: RFA NS 21 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH21 2104", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.